AIRLINK 196.50 Increased By ▲ 2.94 (1.52%)
BOP 10.25 Increased By ▲ 0.30 (3.02%)
CNERGY 7.88 Decreased By ▼ -0.05 (-0.63%)
FCCL 39.80 Decreased By ▼ -0.85 (-2.09%)
FFL 17.09 Increased By ▲ 0.23 (1.36%)
FLYNG 27.12 Decreased By ▼ -0.63 (-2.27%)
HUBC 133.95 Increased By ▲ 1.37 (1.03%)
HUMNL 14.10 Increased By ▲ 0.21 (1.51%)
KEL 4.78 Increased By ▲ 0.18 (3.91%)
KOSM 6.64 Increased By ▲ 0.02 (0.3%)
MLCF 47.18 Decreased By ▼ -0.42 (-0.88%)
OGDC 214.79 Increased By ▲ 0.88 (0.41%)
PACE 6.96 Increased By ▲ 0.03 (0.43%)
PAEL 42.00 Increased By ▲ 0.76 (1.84%)
PIAHCLA 17.15 No Change ▼ 0.00 (0%)
PIBTL 8.50 Increased By ▲ 0.09 (1.07%)
POWER 9.60 Decreased By ▼ -0.04 (-0.41%)
PPL 183.96 Increased By ▲ 1.61 (0.88%)
PRL 42.90 Increased By ▲ 0.94 (2.24%)
PTC 25.15 Increased By ▲ 0.25 (1%)
SEARL 109.80 Increased By ▲ 2.96 (2.77%)
SILK 1.00 Increased By ▲ 0.01 (1.01%)
SSGC 44.11 Increased By ▲ 4.01 (10%)
SYM 17.86 Increased By ▲ 0.39 (2.23%)
TELE 8.96 Increased By ▲ 0.12 (1.36%)
TPLP 13.06 Increased By ▲ 0.31 (2.43%)
TRG 67.60 Increased By ▲ 0.65 (0.97%)
WAVESAPP 11.68 Increased By ▲ 0.35 (3.09%)
WTL 1.83 Increased By ▲ 0.04 (2.23%)
YOUW 3.97 Decreased By ▼ -0.10 (-2.46%)
BR100 12,249 Increased By 204.5 (1.7%)
BR30 36,933 Increased By 352.6 (0.96%)
KSE100 115,663 Increased By 1625.1 (1.43%)
KSE30 36,398 Increased By 603.9 (1.69%)
Business & Finance

Walgreens forecasts 2021 profit growth after Q4 earnings beat

  • The company said it expects strong adjusted profit growth in the second half of 2021, as impact of the COVID-19 pandemic subsides, and supported by its recovery plans.
Published October 15, 2020

Drugstore chain Walgreens Boots Alliance Inc said on Thursday it expects profit to grow in single digits in 2021, after posting a better-than-expected fourth-quarter profit, helped by higher sales at US pharmacies.

Shares of the largest US drugstore chain rose 2.8pc to $36.93.

The company said it expects strong adjusted profit growth in the second half of 2021, as impact of the COVID-19 pandemic subsides, and supported by its recovery plans.

Last quarter, the company suffered a significant decline in footfall in its UK-based retail pharmacies, and resorted to store closures, job cuts and suspension of share repurchases.

Same-store sales at the company's retail pharmacy division in the United States rose 3.6pc from a year earlier.

Excluding items, Walgreens earned $1.02 per share, beating analysts' expectations of 96 cents per share.

Comments

Comments are closed.